What is eBlu Solutions?
eBlu Solutions operates a secure software platform designed to streamline the complex and often fragmented process of electronic prior authorization and benefits verification within the infusion-based specialty medication sector. By digitizing and simplifying these critical administrative steps, the company supports a diverse range of medical specialties, including rheumatology, neurology, gastroenterology, and allergy & asthma. This focus on efficiency and compliance addresses a significant pain point for healthcare providers navigating the intricate approval pathways for high-cost specialty treatments.
How much funding has eBlu Solutions raised?
eBlu Solutions has raised a total of $11.6M across 2 funding rounds:
Debt
$150K
Series A
$11.4M
Debt (2020): $150K with participation from PPP
Series A (2021): $11.4M led by OCA Ventures, FCA Venture Partners, and Mutual Capital Partners LLC
Key Investors in eBlu Solutions
OCA Ventures
OCA Ventures is a venture capital firm dedicated to assisting entrepreneurs in the development of successful companies, providing support and resources to help startups thrive in their respective markets.
FCA Venture Partners
FCA Venture Partners, formerly Clayton Associates, invests in start-up and early-stage companies, evolving from an incubator model to managing venture capital funds focused on emerging businesses.
Mutual Capital Partners LLC
Mutual Capital Partners LLC is an investment entity that has participated in the funding round for eBlu Solutions. Further details on their specific investment focus are not publicly available.
What's next for eBlu Solutions?
The substantial enterprise-level funding, particularly the recent strategic investment, positions eBlu Solutions for accelerated growth and market expansion. This capital infusion is likely to fuel further development of its platform, enhance its technological capabilities, and broaden its reach across more medical specialties and healthcare systems. The company's trajectory suggests a move towards solidifying its market leadership and potentially exploring new service offerings that further integrate the revenue cycle management for specialty pharmaceuticals.
See full eBlu Solutions company page
